Literature DB >> 9795769

Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice.

M A Zechel1, M D Krawetz, B Singh.   

Abstract

Autoimmune T-cell responses to peptide determinants of several autoantigens have recently been characterized. These data suggest that, in some autoimmune models, such as experimental autoimmune encephalomyelitis, T-cell responses may diversify from a nested set of peptides to include many other peptide regions. A similar immune phenomenon pertaining to autoimmune diabetes (IDDM) is observed in NOD mice. We have explored a similar pattern of T-cell responses related to age and disease status in NOD mice termed epitope dominance, which describes immune responses toward a pronounced subset of determinants of the autoantigen glutamic acid decarboxylase (GAD). Our studies have identified a total of five GAD epitopes between the 65 and 67 kDa isoforms. The magnitude of T-cell responses to these various determinants was dependent on the stage of disease as well as on whether mice were protected from disease. The T-cell responses of these epitopes in NOD mice correlated with the predicted binding of these peptides to the NOD class II molecule I-Ag7. We therefore propose a model which implicates antigen presenting cells as critical entities in the propagation of dominant responses to the presentation of autoantigens to T cells, particularly in the Th 1 environment of the NOD mouse. This hypothesis presents a new framework for the discussion and interpretation of the kinetics of T-cell responses to different peptide epitopes in autoimmune diseases such as IDDM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795769     DOI: 10.1111/j.1600-065x.1998.tb01213.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  9 in total

Review 1.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cells.

Authors:  A-S Bergot; A Durgeau; B Levacher; B M Colombo; J L Cohen; D Klatzmann
Journal:  Cancer Gene Ther       Date:  2010-05-14       Impact factor: 5.987

Review 3.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

4.  Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice.

Authors:  T Yamamoto; E Yamato; F Tashiro; T Sato; S Noso; H Ikegami; S Tamura; Y Yanagawa; J-I Miyazaki
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

5.  Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.

Authors:  Hirofumi Shoda; Keishi Fujio; Mihoko Shibuya; Tomohisa Okamura; Shuji Sumitomo; Akiko Okamoto; Tetsuji Sawada; Kazuhiko Yamamoto
Journal:  Arthritis Res Ther       Date:  2011-11-22       Impact factor: 5.156

6.  Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.

Authors:  Ramiro Diz; Alaina Garland; Benjamin G Vincent; Mark C Johnson; Nicholas Spidale; Bo Wang; Roland Tisch
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 7.  Beta-cell mass and type 1 diabetes: going, going, gone?

Authors:  Eitan Akirav; Jake A Kushner; Kevan C Herold
Journal:  Diabetes       Date:  2008-11       Impact factor: 9.461

8.  T-cell promiscuity in autoimmune diabetes.

Authors:  Li Li; Bo Wang; Jeffrey A Frelinger; Roland Tisch
Journal:  Diabetes       Date:  2008-05-20       Impact factor: 9.461

9.  Circulating β cell-specific CD8+ T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes.

Authors:  L Yeo; I Pujol-Autonell; R Baptista; M Eichmann; D Kronenberg-Versteeg; S Heck; G Dolton; A K Sewell; T Härkönen; M-L Mikk; J Toppari; R Veijola; M Knip; J Ilonen; M Peakman
Journal:  Clin Exp Immunol       Date:  2019-11-10       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.